CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China flag China · Delayed Price · Currency is CNY
34.00
-0.67 (-1.93%)
At close: Feb 6, 2026

SHE:300765 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
802.82872.083,7702,1961,2441,139
Short-Term Investments
-355.53----
Trading Asset Securities
430.45470.09--413.59321.94
Cash & Short-Term Investments
1,2331,6983,7702,1961,6581,461
Cash Growth
-4.66%-54.97%71.71%32.43%13.51%1.77%
Accounts Receivable
681.3559.76560.78716.75508.94303.96
Other Receivables
8.912.051.551.561.371.8
Receivables
690.21561.81562.32718.31510.31305.76
Inventory
456.28398.67224.82238.13262111
Other Current Assets
556.9144.2260.2938.4756.9235.6
Total Current Assets
2,9372,8024,6183,1912,4871,913
Property, Plant & Equipment
2,7062,6682,3121,055926.42727.49
Long-Term Investments
279.06264.45267.07253.49243.19235.87
Goodwill
-----3.47
Other Intangible Assets
220.45225.21231.5950.4252.8155.21
Long-Term Deferred Tax Assets
18.4121.6117.3618.8812.510.39
Other Long-Term Assets
49.8540.2926.3315.919.069.43
Total Assets
6,2116,0227,4724,5843,7412,955
Accounts Payable
611.31396.211,264178.75129.1764.16
Accrued Expenses
27.5164.5966.1166.2454.5725.1
Current Portion of Long-Term Debt
---0.22--
Current Portion of Leases
0.390.840.81-0.84-
Current Income Taxes Payable
11.917.1528.3634.7714.9510.26
Current Unearned Revenue
30.1418.6819.868.2630.3725.27
Other Current Liabilities
1,221936.82524.42234.52178.75109.46
Total Current Liabilities
1,9021,4341,904582.77408.64234.24
Long-Term Debt
---19.8--
Long-Term Leases
--0.84---
Long-Term Unearned Revenue
141.5690.4984.1637.2134.2733.31
Long-Term Deferred Tax Liabilities
2.391.40.020.060.670.45
Total Liabilities
2,0461,5261,989639.84443.58268
Common Stock
1,4051,4051,171618.93546420
Additional Paid-In Capital
983.86977.272,1251,1381,211882.28
Retained Earnings
1,6151,6671,9882,1771,5331,376
Treasury Stock
-321.03-321.03-4.25---
Comprehensive Income & Other
5.022.51.980.72-1.2-0.1
Total Common Equity
3,6883,7315,2813,9363,2892,678
Minority Interest
477.07765.39202.458.598.268.79
Shareholders' Equity
4,1654,4965,4833,9443,2982,687
Total Liabilities & Equity
6,2116,0227,4724,5843,7412,955
Total Debt
0.390.841.6520.020.84-
Net Cash (Debt)
1,2331,6973,7692,1761,6571,461
Net Cash Growth
-4.61%-54.97%73.21%31.29%13.45%1.77%
Net Cash Per Share
0.891.212.701.631.241.24
Filing Date Shares Outstanding
1,3931,3931,4051,3371,1791,179
Total Common Shares Outstanding
1,3931,3931,4051,3371,1791,179
Working Capital
1,0351,3682,7142,6082,0791,679
Book Value Per Share
2.652.683.762.942.792.27
Tangible Book Value
3,4673,5055,0493,8853,2372,619
Tangible Book Value Per Share
2.492.523.592.912.742.22
Buildings
-1,020973.56609.24430.75397.71
Machinery
-1,9391,821925.79701.65475.66
Construction In Progress
-620.23228.7170.74294.97154.83
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.